Despite a potentially record-breaking year for the cell and gene therapy industry, certain challenges remain. Precision’s Anshul Mangal identifies ways innovation can overcome hurdles that may ultimately stand in the way of broader accessibility.
Despite a potentially record-breaking year for the cell and gene therapy industry, certain challenges remain. Precision’s Anshul Mangal identifies ways innovation can overcome hurdles that may ultimately stand in the way of broader accessibility.